Profile data is unavailable for this security.
About the company
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
- Revenue in USD (TTM)23.10m
- Net income in USD-51.90m
- Incorporated2006
- Employees193.00
- LocationRapid Micro Biosystems Inc1001 Pawtucket Blvd.LOWELL 01854United StatesUSA
- Phone+1 (978) 349-3200
- Fax+1 (302) 636-5401
- Websitehttps://www.rapidmicrobio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viracta Therapeutics Inc | 0.00 | -51.06m | 32.24m | 40.00 | -- | 2.49 | -- | -- | -1.32 | -1.32 | 0.00 | 0.4686 | 0.00 | -- | -- | 0.00 | -66.88 | -86.35 | -97.91 | -106.38 | -- | -- | -- | -11,853.94 | -- | -141.21 | 0.5798 | -- | -- | -- | -3.78 | -- | -- | -- |
| Mink Therapeutics Inc | 0.00 | -22.46m | 32.27m | 31.00 | -- | -- | -- | -- | -0.6538 | -0.6538 | 0.00 | -0.5219 | 0.00 | -- | -- | 0.00 | -172.59 | -- | -2,317.47 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 19.77 | -- | -- | -- |
| Singular Genomics Systems Inc | 2.91m | -94.82m | 32.38m | 255.00 | -- | 0.1806 | -- | 11.12 | -1.30 | -1.30 | 0.04 | 2.42 | 0.0098 | 0.2182 | 3.94 | 11,415.69 | -31.96 | -- | -33.80 | -- | -19.17 | -- | -3,257.30 | -- | 9.77 | -- | 0.0474 | -- | 280.52 | -- | -4.34 | -- | -- | -- |
| Surrozen Inc | 0.00 | -43.04m | 32.63m | 42.00 | -- | 0.5547 | -- | -- | -21.35 | -21.35 | 0.00 | 18.39 | 0.00 | -- | -- | 0.00 | -63.52 | -- | -72.56 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -19.55 | -- | -- | -- |
| RenovoRx Inc | 0.00 | -10.23m | 32.81m | 8.00 | -- | -- | -- | -- | -1.01 | -1.01 | 0.00 | -0.2805 | 0.00 | -- | -- | 0.00 | -234.38 | -- | -317.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -3.47 | -- | -- | -- |
| Palatin Technologies, Inc. | 7.10m | -30.91m | 33.08m | 34.00 | -- | -- | -- | 4.66 | -2.48 | -2.48 | 0.5582 | -0.7956 | 0.3118 | 0.8717 | 3.42 | 208,755.90 | -135.79 | -26.11 | -269.84 | -30.68 | 95.34 | -- | -435.53 | -126.20 | 1.09 | -- | -- | -- | 230.53 | -40.87 | 23.91 | -- | 80.82 | -- |
| LianBio - ADR | 0.00 | -87.98m | 33.50m | 163.00 | -- | 0.1642 | -- | -- | -0.8195 | -0.8195 | 0.00 | 1.89 | 0.00 | -- | -- | 0.00 | -28.62 | -- | -35.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 43.82 | -- | -- | -- |
| Fortress Biotech Inc | 84.51m | -68.67m | 33.66m | 186.00 | -- | 1.17 | -- | 0.3983 | -8.88 | -8.88 | 10.29 | 1.49 | 0.366 | 2.19 | 3.89 | 454,371.00 | -66.76 | -52.50 | -117.74 | -99.46 | 68.45 | 63.17 | -182.40 | -236.94 | 1.26 | -11.31 | 0.9758 | -- | 11.58 | 25.75 | 27.42 | -- | -9.37 | -- |
| Rapid Micro Biosystems Inc | 23.10m | -51.90m | 34.15m | 193.00 | -- | 0.3218 | -- | 1.48 | -1.20 | -1.20 | 0.5355 | 2.48 | 0.1535 | 1.37 | 4.34 | 119,663.20 | -34.49 | -- | -38.20 | -- | -22.59 | -- | -224.73 | -- | 5.62 | -- | 0.0028 | -- | 31.44 | -- | 13.71 | -- | -- | -- |
| Earth Science Tech Inc | 5.98m | 330.94k | 34.63m | 8.00 | 114.58 | 16.05 | 65.44 | 5.79 | 0.001 | 0.001 | 0.0195 | 0.0069 | 3.16 | 11.41 | 106.07 | 747,970.00 | 17.50 | -224.84 | 42.70 | -- | 62.29 | 37.79 | 5.53 | -333.58 | 0.386 | -0.3899 | 0.1023 | -- | 243.77 | -36.31 | -111.95 | -- | -- | -- |
| Spruce Biosciences Inc | 10.09m | -47.92m | 34.79m | 29.00 | -- | 0.4534 | -- | 3.45 | -1.26 | -1.26 | 0.2622 | 1.86 | 0.1064 | -- | -- | 347,896.60 | -50.55 | -41.24 | -62.77 | -46.49 | -- | -- | -474.96 | -1,774.39 | -- | -107.65 | 0.0418 | -- | -- | -- | -3.77 | -- | -- | -- |
| CASI Pharmaceuticals Inc | 33.88m | -26.96m | 35.38m | 176.00 | -- | 1.46 | -- | 1.04 | -2.02 | -2.02 | 2.54 | 1.81 | 0.3951 | 1.26 | 3.01 | 192,494.30 | -30.57 | -34.75 | -45.42 | -46.91 | 59.19 | 55.98 | -77.37 | -153.72 | 2.60 | -- | 0.4388 | -- | -21.41 | -- | 34.27 | -- | 14.65 | -- |
| Nuo Therapeutics Inc | 608.53k | -3.17m | 35.39m | -- | -- | 34.06 | -- | 58.16 | -0.0754 | -0.0754 | 0.0145 | 0.0235 | 0.2471 | 0.5609 | 3.55 | -- | -128.78 | -116.16 | -173.76 | -354.84 | 79.28 | 70.02 | -521.17 | -854.53 | 2.01 | -1,002.61 | 0.00 | -- | 442.12 | -14.99 | 0.0095 | -- | -- | -- |
| IGC Pharma Inc | 1.22m | -14.15m | 35.91m | 61.00 | -- | 3.80 | -- | 29.53 | -0.2479 | -0.2479 | 0.0217 | 0.142 | 0.0776 | 0.2084 | 7.09 | 19,934.43 | -90.30 | -33.35 | -100.90 | -35.84 | 51.40 | 8.74 | -1,163.24 | -410.26 | 0.8564 | -- | 0.0153 | -- | 129.47 | -16.11 | 23.38 | -- | 25.28 | -- |
| Promis Neurosciences Inc | 0.00 | -13.21m | 36.49m | 6.00 | -- | 9.68 | -- | -- | -1.22 | -1.22 | 0.00 | 0.1987 | 0.00 | -- | -- | 0.00 | -128.63 | -144.28 | -552.70 | -262.23 | -- | -- | -- | -2,271,047.00 | -- | -- | 0.00 | -- | -- | -- | 26.85 | -- | -- | -- |
Data as of May 09 2024. Currency figures normalised to Rapid Micro Biosystems Inc's reporting currency: US Dollar USD
26.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kennedy Lewis Management LPas of 31 Mar 2024 | 4.94m | 13.28% |
| Glenview Capital Management LLCas of 31 Dec 2023 | 1.32m | 3.55% |
| BlackRock Advisors LLCas of 31 Dec 2023 | 947.80k | 2.55% |
| JPMorgan Securities LLC (Investment Management)as of 31 Dec 2023 | 750.04k | 2.02% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 728.37k | 1.96% |
| Adage Capital Management LPas of 31 Dec 2023 | 700.00k | 1.88% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 2023 | 218.29k | 0.59% |
| Geode Capital Management LLCas of 31 Dec 2023 | 155.26k | 0.42% |
| Next Edge Capital Corp.as of 31 Dec 2023 | 90.00k | 0.24% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 77.89k | 0.21% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
